Nasdaq · Healthcare
BrightSpring Health Services, Inc. (BTSG)
As-reported financials and recent SEC filings for BrightSpring Health Services, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$12.91B
Net income
$190.7M
Net margin
1.5%
Diluted EPS
$0.87
ROE
10.2%
P/E (TTM)
89.6×
Market cap
$13.54B
Debt / equity
1.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2024 | FY2024 |
|---|---|---|---|---|
| Revenue | $12.91B | $10.07B | $7.69B | $7.72B |
| Gross profit | — | — | — | — |
| Operating income | $295.3M | $108.0M | $58.1M | $187.8M |
| Net income | $190.7M | $-18.1M | $-154.6M | $-53.9M |
| Diluted EPS | $0.87 | $-0.09 | $-1.31 | $-0.46 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-22
View on EDGAR →8-K2026-06-12
View on EDGAR →42026-06-12
View on EDGAR →32026-06-12
View on EDGAR →424B72026-06-05
View on EDGAR →8-K2026-06-05
View on EDGAR →SCHEDULE 13D/A2026-06-05
View on EDGAR →42026-06-05
View on EDGAR →Go deeper on BTSG
Search BrightSpring Health Services, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.